Preclinical evaluation of 99mTc-EC20 for imaging folate receptor-positive tumors

Journal of Nuclear Medicine

Volumn 45, Issue 5, 2004, Pages 857-866

  Reddy, Joseph A ^a   Xu, Le Cun ^a   Parker, Nikki ^a   Vetzel, Marilynn ^a   Leamon, Christopher P ^a  

^a Endocyte Inc   (United States)

Author keywords

99mTc; Endocytosis; Folate receptor; Tumor imaging; Tumor targeting

Indexed keywords

EC20 TC 99M; FOLATE RECEPTOR; FOLINIC ACID; TRACER; UNCLASSIFIED DRUG; CARRIER PROTEIN; CELL SURFACE RECEPTOR; CYSTEINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FOLATE BINDING PROTEIN; FOLATE-BINDING PROTEIN; FOLIC ACID; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M ETHYLENEDICYSTEINE FOLATE; TECHNETIUM TC 99M-ETHYLENEDICYSTEINE-FOLATE;

ARTICLE; BINDING AFFINITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; RADIOCHEMISTRY; SYNTHESIS; TUMOR; TUMOR LOCALIZATION; TUMOR VOLUME; ANIMAL; BAGG ALBINO MOUSE; EXPERIMENTAL NEOPLASM; FEMALE; METABOLISM; SCINTISCANNING; TISSUE DISTRIBUTION;

ANIMALS; CARRIER PROTEINS; CYSTEINE; FEMALE; FOLIC ACID; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; RECEPTORS, CELL SURFACE; TISSUE DISTRIBUTION;

EID: 2642514921     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Breeman WA, de Jong M, Kwekkeboom DJ, et al. Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives. Eur J Nucl Med. 2001;28:1421-1429.
2. 99mTc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis. Semin Nucl Med. 1999;29:16-40.
3. Weitman SD, Lark RH, Coney LR, et al. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 1992;52:3396-3401.
4. Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines: physiologic and clinical implications. Cancer. 1994;73:2432-2443.
5. Toffoli G, Cernigoi C, Russo A, Gallo A, Bagnoli M, Boiocchi M. Overexpression of folate binding protein in ovarian cancers. Int J Cancer. 1997;74:193-198.
6. Leamon CP, Low PS. Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Proc Natl Acad Sci USA. 1991;88:5572-5576.
7. Leamon CP, Low PS. Folate-mediated targeting: from diagnostics to drug and gene delivery. Drug Discov Today. 2001;6:44-51.
8. Reddy JA, Low PS. Folate-mediated targeting of therapeutic and imaging agents to cancers. Crit Rev Ther Drug Carrier Syst. 1998;15:587-627.
9. Leamon CP, Pastan I, Low PS. Cytotoxicity of folate-Pseudomonas exotoxin conjugates toward tumor cells: contribution of translocation domain. J Biol Chem. 1993;268:24847-24854.
10. Rund LA, Cho BK, Manning TC, Holler PD, Roy EJ, Kranz DM. Bispecific agents target endogenous murine T cells against human tumor xenografts. Int J Cancer. 1999;83:141-149.
11. Lu Y, Low PS. Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors. Cancer Immunol Immunother. 2002;51:153-162.
12. Lee RJ, Low PS. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J Biol Chem. 1994;269:3198-3204.
13. Reddy JA, Dean D, Kennedy MD, Low PS. Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy. J Pharm Sci. 1999;88:1112-1118.
14. Reddy JA, Abburi C, Hofland H, et al. Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors. Gene Ther. 2002;9:1542-1550.
15. 67Ga-deferoxamine-folate, a potential radiopharmaceutical for tumor imaging. Bioconjug Chem. 1996;7:56-62.
16. Mathias CJ, Wang S, Lee RJ, Waters DJ, Low PS, Green MA. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate. J Nucl Med. 1996;37:1003-1008.
17. 111In]DTPA-folate for use as a tumor-targeted radiopharmaceutical. Bioconjug Chem. 1997;8:673-679.
18. Mathias CJ, Wang S, Waters DJ, Turek JJ, Low PS, Green MA. Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical. J Nucl Med. 1998;39:1579-1585.
19. 99mTc-Labeled small peptides as diagnostic radiopharmaceuticals. Chem Rev. 1999;99:2235-2268.
20. 99mTc-HYNIC-folate: a novel receptor-based targeted radiopharmaceutical for tumor imaging. J Nucl Med. 1999;40:1563-1569.
21. 99mTc-Ethylenedicysteine- folate: a new tumor imaging agent - synthesis, labeling and evaluation in animals. Cancer Biother Radiopharm. 1998;13:427-435.
22. 99mTc]DTPA-folate and its evaluation as a folate-receptor-targeted radiopharmaceutical. Bioconjug Chem. 2000;11:253-257.
23. 99mTc-based radiopharmaceutical. Bioconjug Chem. 2002;13:1200-1210.
24. Westerhof GR, Schornagel JH, Kathmann I, et al. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity. Mol Pharmacol. 1995;48:459-471.
25. Schmitz JC, Stuart RK, Priest DG. Disposition of folic acid and its metabolites: a comparison with leucovorin. Clin Pharmacol Ther. 1994;55:501-508.
26. Reddy JA, Low PS. Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation. J Control Release. 2000;64:27-37.
27. Jain RK. Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev. 1990;9:253-266.
28. Jain RK. Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J Natl Cancer Inst. 1989;81:570-576.
29. Pestieau SR, Stuart OA, Sugarbaker PH. Multi-targeted antifolate (MTA): pharmacokinetics of intraperitoneal administration in a rat model. Eur J Surg Oncol. 2000;26:696-700.
30. Stanger O. Physiology of folic acid in health and disease. Curr Drug Metab. 2002;3:211-223.
31. Donnelly JG. Folic acid. Crit Rev Clin Lab Sci. 2001;38:183-223.
32. Hall JG, Solehdin F. Folate and its various ramifications. Adv Pediatr. 1998;45:1-35.
33. Huennekens FM, Vitols KS, Henderson GB. Transport of folate compounds in bacterial and mammalian cells. Adv Enzymol Relat Areas Mol Biol. 1978;47:313-346.
34. Leichman CG, Fleming TR, Muggia FM, et al. Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study. J Clin Oncol. 1995;13:1303-1311.
35. Levin RD, Gordon JH. Fluorodeoxyuridine with continuous leucovorin infusion: a phase II clinical trial in patients with metastatic colorectal cancer. Cancer. 1993;72:2895-2901.